(SUZ) Suzano Papel e Celulose - Ratings and Ratios
Pulp, Paper, Paperboards, Tissue Papers, Biofuel
SUZ EPS (Earnings per Share)
SUZ Revenue
Description: SUZ Suzano Papel e Celulose
Suzano S.A. is a Brazilian multinational company operating in the pulp and paper industry, with a diverse product portfolio that includes printing and writing papers, paperboards, tissue papers, and market and fluff pulps. The companys business extends beyond traditional pulp and paper products to include biofuel production, port terminal operations, power generation, and biotechnology research.
From a financial perspective, Suzanos market capitalization stands at approximately $11.2 billion USD, indicating a significant presence in the global market. The companys forward Price-to-Earnings (P/E) ratio is around 9.90, suggesting a relatively reasonable valuation. However, the Return on Equity (RoE) is currently negative at -2.49%, indicating that the company is not generating profits for its shareholders.
To further analyze Suzanos performance, key performance indicators (KPIs) such as revenue growth, EBITDA margin, and debt-to-equity ratio can be examined. Suzanos revenue growth has been driven by its diversified product portfolio and expanding presence in international markets. The companys EBITDA margin, which measures its ability to generate earnings before interest, taxes, depreciation, and amortization, is a crucial indicator of its operational efficiency.
Additionally, Suzanos commitment to sustainability and environmental stewardship is reflected in its forestry practices, with a focus on restoration, conservation, and preservation of forests. The companys research and development activities in biotechnology and cellulose-based products also demonstrate its efforts to innovate and diversify its product offerings.
Overall, Suzanos complex business model and diverse product portfolio require a nuanced analysis of its financial and operational performance. By examining key metrics and industry trends, investors can gain a deeper understanding of the companys strengths and weaknesses, and make informed decisions about its potential for long-term growth and profitability.
SUZ Stock Overview
| Market Cap in USD | 11,870m |
| Sub-Industry | Paper Products |
| IPO / Inception | 1996-02-27 |
SUZ Stock Ratings
| Growth Rating | 1.56% |
| Fundamental | 64.2% |
| Dividend Rating | 27.1% |
| Return 12m vs S&P 500 | -15.1% |
| Analyst Rating | 4.60 of 5 |
SUZ Dividends
| Dividend Yield 12m | 3.45% |
| Yield on Cost 5y | 4.23% |
| Annual Growth 5y | -18.07% |
| Payout Consistency | 63.0% |
| Payout Ratio | 28.0% |
SUZ Growth Ratios
| Growth Correlation 3m | 43.7% |
| Growth Correlation 12m | -39.7% |
| Growth Correlation 5y | 5.5% |
| CAGR 5y | 8.07% |
| CAGR/Max DD 3y | 0.25 |
| CAGR/Mean DD 3y | 0.50 |
| Sharpe Ratio 12m | -1.30 |
| Alpha | -20.87 |
| Beta | 0.987 |
| Volatility | 23.36% |
| Current Volume | 1214.7k |
| Average Volume 20d | 1214.7k |
| Stop Loss | 9.1 (-3.8%) |
| Signal | -1.10 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (7.83b TTM) > 0 and > 6% of Revenue (6% = 3.08b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 3.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 53.20% (prev 59.37%; Δ -6.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 20.24b > Net Income 7.83b (YES >=105%, WARN >=100%) |
| Net Debt (86.13b) to EBITDA (31.73b) ratio: 2.71 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.24b) change vs 12m ago -3.69% (target <= -2.0% for YES) |
| Gross Margin 37.73% (prev 38.83%; Δ -1.10pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.83% (prev 25.71%; Δ 7.12pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.66 (EBITDA TTM 31.73b / Interest Expense TTM 5.87b) >= 6 (WARN >= 3) |
Altman Z'' 2.68
| (A) 0.17 = (Total Current Assets 39.91b - Total Current Liabilities 12.62b) / Total Assets 159.42b |
| (B) 0.07 = Retained Earnings (Balance) 11.43b / Total Assets 159.42b |
| (C) 0.14 = EBIT TTM 21.47b / Avg Total Assets 156.26b |
| (D) 0.38 = Book Value of Equity 44.65b / Total Liabilities 116.15b |
| Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 64.19
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 4.42% = 2.21 |
| 3. FCF Margin 11.72% = 2.93 |
| 4. Debt/Equity 2.14 = 0.56 |
| 5. Debt/Ebitda 2.91 = -1.64 |
| 6. ROIC - WACC 6.53% = 8.16 |
| 7. RoE 20.18% = 1.68 |
| 8. Rev. Trend 7.94% = 0.40 |
| 9. Rev. CAGR -2.36% = -0.39 |
| 10. EPS Trend -28.28% = -0.71 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of SUZ shares?
Over the past week, the price has changed by -1.77%, over one month by -5.68%, over three months by -1.15% and over the past year by +1.03%.
Is Suzano Papel e Celulose a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SUZ is around 9.17 USD . This means that SUZ is currently overvalued and has a potential downside of -3.07%.
Is SUZ a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SUZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.8 | 45.5% |
| Analysts Target Price | 13.8 | 45.5% |
| ValueRay Target Price | 9.9 | 4.3% |
Last update: 2025-09-05 05:02
SUZ Fundamental Data Overview
CCE Cash And Equivalents = 20.37b BRL (Cash And Short Term Investments, last quarter)
P/E Trailing = 8.1624
P/E Forward = 8.0972
P/S = 0.2314
P/B = 1.4965
Beta = 0.374
Revenue TTM = 51.30b BRL
EBIT TTM = 21.47b BRL
EBITDA TTM = 31.73b BRL
Long Term Debt = 88.75b BRL (from longTermDebt, last quarter)
Short Term Debt = 3.72b BRL (from shortTermDebt, last quarter)
Debt = 92.47b BRL (Calculated: Short Term 3.72b + Long Term 88.75b)
Net Debt = 86.13b BRL (from netDebt column, last quarter)
Enterprise Value = 136.07b BRL (63.97b + Debt 92.47b - CCE 20.37b)
Interest Coverage Ratio = 3.66 (Ebit TTM 21.47b / Interest Expense TTM 5.87b)
FCF Yield = 4.42% (FCF TTM 6.01b / Enterprise Value 136.07b)
FCF Margin = 11.72% (FCF TTM 6.01b / Revenue TTM 51.30b)
Net Margin = 15.27% (Net Income TTM 7.83b / Revenue TTM 51.30b)
Gross Margin = 37.73% ((Revenue TTM 51.30b - Cost of Revenue TTM 31.95b) / Revenue TTM)
Tobins Q-Ratio = 3.05 (Enterprise Value 136.07b / Book Value Of Equity 44.65b)
Interest Expense / Debt = 1.74% (Interest Expense 1.61b / Debt 92.47b)
Taxrate = 31.34% (2.29b / 7.30b)
NOPAT = 14.74b (EBIT 21.47b * (1 - 31.34%))
Current Ratio = 3.16 (Total Current Assets 39.91b / Total Current Liabilities 12.62b)
Debt / Equity = 2.14 (Debt 92.47b / last Quarter total Stockholder Equity 43.14b)
Debt / EBITDA = 2.91 (Net Debt 86.13b / EBITDA 31.73b)
Debt / FCF = 15.38 (Debt 92.47b / FCF TTM 6.01b)
Total Stockholder Equity = 38.82b (last 4 quarters mean)
RoA = 4.91% (Net Income 7.83b, Total Assets 159.42b )
RoE = 20.18% (Net Income TTM 7.83b / Total Stockholder Equity 38.82b)
RoCE = 16.83% (Ebit 21.47b / (Equity 38.82b + L.T.Debt 88.75b))
RoIC = 11.18% (NOPAT 14.74b / Invested Capital 131.79b)
WACC = 4.65% (E(63.97b)/V(156.44b) * Re(9.65%)) + (D(92.47b)/V(156.44b) * Rd(1.74%) * (1-Tc(0.31)))
Shares Correlation 3-Years: -93.13 | Cagr: -0.58%
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 63.55% ; FCFE base≈6.01b ; Y1≈3.95b ; Y5≈1.81b
Fair Price DCF = 22.46 (DCF Value 27.75b / Shares Outstanding 1.24b; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 7.94 | Revenue CAGR: -2.36%
Rev Growth-of-Growth: 43.15
EPS Correlation: -28.28 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 239.6
Additional Sources for SUZ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle